Drug Design, Development and Therapy
Journal Title
- Drug Design, Development and Therapy
ISSN
- P 1177-8881
Publisher
- Dove Medical Press Ltd
Listed on(Coverage)
| JCR | 2011-2023 |
|---|---|
| SJR | 2009-2020;2022-2023 |
| CiteScore | 2011-2023 |
| SCIE | 2012-2024 |
| SCOPUS | 2017-2024 |
| MEDLINE | 2016-2024 |
| DOAJ | 2017-2024 |
| EMBASE | 2016-2024 |
OA Info.
| OA |
based on the information
|
|---|---|
| Keywords | drug design, drug safety, drug development, pharmaecuticals |
| Review Process | Anonymous peer review |
| Journal info. pages | |
| Licences | CC BY, CC BY-NC |
| Copyrights | No |
| DOAJ Coverage |
|
| Subject(s) | Medicine: Therapeutics. Pharmacology |
Active
- Active
based on the information
- SCOPUS:2024-10
Country
- NEW ZEALAND
Aime & Scopes
- Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications. The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas. Specific topics covered by the journal include: /// Drug target identification and validation /// Phenotypic screening and target deconvolution /// Biochemical analyses of drug targets and their pathways /// New methods or relevant applications in molecular/drug design and computer-aided drug discovery* /// Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes) /// Structural or molecular biological studies elucidating molecular recognition processes /// Fragment-based drug discovery /// Pharmaceutical/red biotechnology /// Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products** /// Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development /// Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing) /// Preclinical development studies /// Translational animal models /// Mechanisms of action and signalling pathways /// Toxicology /// Gene therapy, cell therapy and immunotherapy /// Personalized medicine and pharmacogenomics /// Clinical drug evaluation /// Patient safety and sustained use of medicines